PDIA3 and ovarian cancer: Similar to our observations, recent studies showed that overexpressed ERp57 is a marker for chemoresistance of ovarian cancer, as identified by proteomic analysis [30, 31], and the expression levels of disulfide isomerase family proteins are linked with drug resistance in multiple tumor types [32, 33].